IP Pharma

Thursday, February 10, 2005

Open-source biotech takes a step forward

An article in this week's Nature publicizes two new biotech tools, both available as open-source applications to researchers willing to sign a "creative commons-type" license.

The paper describes two new technologies: TransBacter, a method for transferring genes to plants, and GUSPlus, a method of visualizing where the genes are and what they do. Behind the research, which was funded by the Rockefeller Foundation, is a team of scientists who want to provide the technologies as a "kernel," modeled on the Linux movement, as the beginning of perhaps the first practical offering in open-source biology.

Researchers who want to develop technologies based on this kernel can use it as they wish if they agree to a flexible license issued by Biological Innovation for Open Society, or BIOS.

0 Comments:

Post a Comment

<< Home